Evidence map›Paper›PMID 28296622›Full record

ArticleCell cycle (Georgetown, Tex.)2017

A cell based screening approach for identifying protein degradation regulators.

Scott Simanski, Marie E Maloof, Trey K Sato, Valerie Cavett, Jennifer Caldwell Busby, Nagi G Ayad

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Scott Simanskia Department of Cancer Biology , Scripps Florida, The Scripps Research Institute , Jupiter , FL , USA.
Marie E Maloofb Department of Psychiatry and Behavioral Sciences , Center for Therapeutic Innovation, Sylvester Comprehensive Cancer Center , Miami , FL , USA.
Trey K Satoc Department of Molecular Therapeutics , Scripps Florida, The Scripps Research Institute , Jupiter , FL , USA.
Valerie Cavettc Department of Molecular Therapeutics , Scripps Florida, The Scripps Research Institute , Jupiter , FL , USA.ORCID http://orcid.org/0000-0003-2859-6355
Jennifer Caldwell Busbyc Department of Molecular Therapeutics , Scripps Florida, The Scripps Research Institute , Jupiter , FL , USA.
Nagi G Ayadb Department of Psychiatry and Behavioral Sciences , Center for Therapeutic Innovation, Sylvester Comprehensive Cancer Center , Miami , FL , USA.
Scripps Research Institute · USSylvester Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular transitions are achieved by the concerted actions of regulated degradation pathways. In the case of the cell cycle, ubiquitin mediated degradation ensures unidirectional transition from one phase to another. For instance, turnover of the cell cycle regulator cyclin B1 occurs after metaphase to induce mitotic exit. To better understand pathways controlling cyclin B1 turnover, the N-terminal domain of cyclin B1 was fused to luciferase to generate an N-cyclin B1-luciferase protein that can be used as a reporter for protein turnover. Prior studies demonstrated that cell-based screens using this reporter identified small molecules inhibiting the ubiquitin ligase controlling cyclin B1-turnover. Our group adapted this approach for the G2-M regulator Wee1 where a Wee1-luciferase construct was used to identify selective small molecules inhibiting an upstream kinase that controls Wee1 turnover. In the present study we present a screening approach where cell cycle regulators are fused to luciferase and overexpressed with cDNAs to identify specific regulators of protein turnover. We overexpressed approximately 14,000 cDNAs with the N-cyclin B1-luciferase fusion protein and determined its steady-state level relative to other luciferase fusion proteins. We identified the known APC/C regulator Cdh1 and the F-box protein Fbxl15 as specific modulators of N-cyclin B1-luciferase steady-state levels and turnover. Collectively, our studies suggest that analyzing the steady-state levels of luciferase fusion proteins in parallel facilitates identification of specific regulators of protein turnover.

Indexed as

Antigens, CDCadherinsCell CycleCell Cycle ProteinsCyclin B1F-Box ProteinsGene Expression Regulation, DevelopmentalHeLa CellsHumansLuciferasesMitosisNuclear ProteinsProtein-Tyrosine KinasesProteolysisRecombinant Fusion ProteinsUbiquitinAntigens, CDCadherinsCCNB1 protein, humanCDH1 protein, humanCell Cycle ProteinsCyclin B1F-Box ProteinsLuciferasesNuclear ProteinsProtein-Tyrosine KinasesRecombinant Fusion ProteinsUbiquitinWEE1 protein, humancell-based screeningdegradationluciferasesubstrateubiquitin

Identifiers

PMID28296622
PMCPMC5462078
OpenAlexW2608975044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.